Cost-Controlled Flexible Cleanroom Solutions – Balancing the Development Needs of Innovative Pharma Companies with Investment Pressures. Given the extended development cycles and substantial capital requirements of innovative drug R&D, how to control infrastructure investment while meeting production requirements poses a common challenge for many innovative pharmaceutical companies. To address the phased needs of innovative pharma companies during pilot-scale scale-up and small-scale sterile production, we have developed cleanroom space solutions characterized by controllable investment, flexible scalability, and optimized O&M costs, helping enterprises balance production capacity demands with financial constraints in their early growth stages. Our solution employs a modular electrostatic steel plate enclosure system, which can be constructed in phases according to current production requirements, enabling rapid expansion for future capacity increases without requiring excessive upfront investment. Core components feature high-grade HEPA filtration systems that not only meet cleanroom classification standards but also leverage variable frequency drive (VFD) control to achieve energy-efficient operation, thereby reducing daily operating costs. A smart environmental monitoring system enables automated monitoring and early warning mechanisms, reducing the workload of manual inspections and lowering labor costs. For critical production areas, we implement enhanced leak-proof sealing designs on an as-needed basis, while modular components can be selectively integrated for specialized functions—such as radiation protection—without the need for upfront payments for unused features. The overall design complies with GMP validation requirements and ensures cleanroom accessibility, while optimizing full lifecycle costs to help enterprises reduce their total cost of ownership. Adhering to a long-term service philosophy, we continuously upgrade our cleanroom solutions in tandem with the growth of our clients, fostering mutual development with innovative pharmaceutical companies.